Merck
(NYSE) MRK
Merck Financials at a Glance
Market Cap
$295.39B
Revenue (TTM)
$65.59B
Net Income (TTM)
$8.94B
EPS (TTM)
$3.55
P/E Ratio
33.66
Dividend
$3.36
Beta (Volatility)
0.28 (Low)
Dividend
$3.36
Beta (Volatility)
0.28 (Low)
Price
$120.78
Volume
302,470
Open
$120.16
Price
$120.78
Volume
302,470
Open
$120.16
Previous Close
$120.78
Daily Range
$119.52 - $121.80
52-Week Range
$76.66 - $125.14
Estimated Earnings Date
Aug 4, 2026
Dividend
$3.36
Beta (Volatility)
0.28 (Low)
Price
$120.78
Volume
302,470
Open
$120.16
Previous Close
$120.78
Daily Range
$119.52 - $121.80
52-Week Range
$76.66 - $125.14
Estimated Earnings Date
Aug 4, 2026
MRK News
Dow Jones Industrial Average
MRK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Merck
Industry
Pharmaceuticals
Sector
Health CareEmployees
75,000
CEO
Robert M. Davis, MBA
Website
www.merck.comHeadquarters
Rahway, NJ 07065, US
MRK Financials
Key Financial Metrics (TTM)
Gross Margin
75.91%
Operating Margin
27.59%
Net Income Margin
13.62%
Return on Equity
17.93%
Return on Capital
22.77%
Return on Assets
6.94%
Earnings Yield
2.97%
Dividend Yield
2.81%
Payout Ratio
92.12%
Stock Overview
Market Cap
$295.39B
Shares Outstanding
2.47B
Volume
302.47K
Avg. Volume
9.99M
Financials (TTM)
Gross Profit
$49.79B
Operating Income
$18.10B
EBITDA
$18.78B
Operating Cash Flow
$17.89B
Capital Expenditure
-$3.78B
Free Cash Flow
$14.12B
Cash & ST Invst.
$5.70B
Total Debt
$49.12B
Merck Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.29B
+4.3%
Gross Profit
$13.34B
+13.7%
Gross Margin
81.92%
N/A
Market Cap
$295.39B
N/A
Market Cap/Employee
$4.05M
N/A
Employees
73,000
N/A
Net Income
-$4.24B
-183.5%
EBITDA
-$2.02B
-127.6%
Quarterly Fundamentals
Total Cash
$5.70B
-38.2%
Total Debt
$49.12B
+41.0%
Accounts Receivable
$12.21B
+13.2%
Inventory
$6.48B
+4.6%
Long Term Debt
$46.67B
+39.4%
Short Term Debt
$2.44B
+79.7%
Return on Assets
6.94%
N/A
Return on Invested Capital
17.79%
N/A
Free Cash Flow
$2.93B
+149.7%
Operating Cash Flow
$3.92B
+56.7%